Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes: (ADO)- Lupine Publishers

Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes by Nikolaos Papanas in Archives of Diabetes & Obesity in Lupine Publishers 

Over the past years, type 2 diabetes mellitus (T2DM) has become a global pandemic, both in developed and developing countries [1,2]. Its aetiology is multifactorial, including genetic factors, increasing age, obesity and insulin resistance [3]. Among these factors, obesity is of paramount importance, and its management can be of benefit [4,5] by Lupine Publishers.

https://www.lupinepublishers.com/diabetes-obesity-journal/abstracts/sodium-glucose-cotransporter-2-inhibitors-in-the-treatment-of-type-2-diabetes.ID.000111.php

https://www.lupinepublishers.com/diabetes-obesity-journal/fulltext/sodium-glucose-cotransporter-2-inhibitors-in-the-treatment-of-type-2-diabetes.ID.000111.php

https://www.lupinepublishers.com/diabetes-obesity-journal/pdf/ADO.MS.ID.000111.pdf

For more Lupine publishers Open access journalsplease visit our website

https://www.lupinepublishers.com/

For more Diabetes Obesity Journal Open access journal article please click here

https://www.lupinepublishers.com/diabetes-obesity-journal/